Hämatologisch-Onkologische Praxis Augsburg

Augsburg, Bavaria 86151

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Breast Cancer, Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Studies at this site

• Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) — Running, not enrolling
• A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer — Withdrawn before enrolling